Liqun Tian

1.2k citations
18 papers · 955 indexed · h-index 13
Topics
Peroxisome Proliferator-Activated Receptors (9 papers)Adipose Tissue and Metabolism (6 papers)Metabolism and Genetic Disorders (5 papers)

In The Last Decade

Liqun Tian

18 papers receiving 938 citations

Peers

Liqun Tian
Comparison fields: 5 of 81
  • Molecular Biology 536
  • Physiology 411
  • Clinical Biochemistry 281
  • Epidemiology 208
  • Cell Biology 94
Replace Sarah E. Seiler with:
Sarah E. Seiler United States
Jolita Čiapaitė Netherlands
James P. Stice United States
A. Brianne Thrush Canada
Georgios Karamanlidis United States
Jean‐François Louet United States
João Duarte United States
Julia T. Stadler Austria
Vian Azzu United Kingdom
Shulan Song United States
Liqun Tian relative to Sarah E. Seiler United States Sarah E. Seiler's profile →
Citations per field
00.5×1.5×2.0×
Sarah E. Seiler · 1×
Citations per year

Countries citing papers authored by Liqun Tian

Since Specialization
Citations

This map shows the geographic impact of Liqun Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liqun Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liqun Tian more than expected).

Fields of papers citing papers by Liqun Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liqun Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liqun Tian. The network helps show where Liqun Tian may publish in the future.

Co-authorship network of co-authors of Liqun Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Liqun Tian. A scholar is included among the top collaborators of Liqun Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liqun Tian. Liqun Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 2
2 1
3 6
4 9
5 74
6 58
7 229
8 59
9 96
10 81
11 25
12 17
13 20
14 18
15 195
16 23
17 41
18 1

About Liqun Tian

Liqun Tian is a scholar working on Clinical Biochemistry, Physiology and Biochemistry, having authored 18 papers that have together received 955 indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (9 papers), Adipose Tissue and Metabolism (6 papers) and Metabolism and Genetic Disorders (5 papers). The work is most often cited by research in Clinical Biochemistry (281 citations), Physiology (411 citations) and Biochemistry (79 citations). Liqun Tian has collaborated with scholars based in United States, China and Netherlands. Frequent co-authors include Philip A. Wood, Cheol Soo Choi, Dongyan Zhang, Zhenxiang Liu, Jianying Dong, Gerald I. Shulman, Doug A. Hamm, Jerry Vockley, Piero Rinaldo and Gary W. Cline. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cell Metabolism and Biochemical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026